Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Bodor
Janos Bodor, Vlaardingen NL
| Patent application number | Description | Published |
|---|---|---|
| 20090258133 | Mayonnaise Product and a Process for Preparing It - A mayonnaise product is provided that has a continuous aqueous phase and a dispersed oil phase. The product comprises 25-87 wt % of oil and contains, expressed on the non-oil content of the product, a combined amount of soy protein and whey protein of 0.5-15 wt %. The weight ratio soy protein:whey protein is between 10:1 and 1:4 and the product is free of egg protein. The product has several advantages over conventional egg based mayonnaise. It has improved structural and sensoric properties compared with mayonnaise products based on other egg replacer formulations. The product can be made by preparing an aqueous dispersion that includes soy protein and whey protein, preparing an oil-in-water emulsion that has an oil content of at least 25 wt % by including oil in the aqueous dispersion, and including acid in the oil-in-water emulsion. | 10-15-2009 |
Nicholas Bodor, Bal Harbour, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20080249165 | Glycosides and Salts Thereof - The invention relates to new polysulfated glycosides of formula (I), the salts thereof formed with alkali metals or alkaline-earth metals, as well as the pharmaceutical compositions containing these compounds as active ingredients. Furthermore the invention provides a method of preventing, treating or alleviating the symptoms of acute and chronic inflammatory disorders of the airways of mammals—including asthma and asthma-related pathologies. | 10-09-2008 |
| 20090215717 | Sulfated oligosaccharides - The invention relates to sulfated oligosaccharides, more particularly to new pharmaceutical uses of sulfated oligosaccharides. The invention provides a method of preventing, treating or alleviating the symptoms of acute and chronic’, inflammatory disorders of the airways of mammals—including asthma and asthma-related pathologies. The invention further provides use of a sulfated oligosaccharide in the preparation of a medicament for the treatment of acute and chronic inflammatory disorders of the airways of mammals. The invention yet further provides use of a sulfated oligosaccharide to preventing, treating or alleviating the symptoms of acute and chronic inflammatory disorders of the airways of mammals—including asthma and asthma-related pathologies. | 08-27-2009 |
| 20100204683 | THERAPEUTIC HYBRID IMPLANTABLE DEVICES | 08-12-2010 |
| 20110118198 | POLYSULFATED GLYCOSIDES AND SALTS THEREOF - The invention relates to polysulfated glycosides of formula (I), the pharmaceutically acceptable salts thereof, as well as the pharmaceutical compositions containing these compounds as active ingredients. Furthermore the invention provides a method of preventing, treating or alleviating the symptoms of acute and chronic inflammatory disorders of the airways of mammals—including asthma and asthma-related pathologies. | 05-19-2011 |
Peter Pal Bodor, Pembroke Pines, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20100245653 | Endoscope Objective Lens and Method of Assembly - A wide field video endoscope objective and method of assembly the objective including four groups with five lenses, a mechanical housing containing the entire image forming elements, a aperture stop, a centering member and a retainer sleeve. The centering member is at first centered over the photo sensitive area of the chip and bonded to the surface of the cover glass. The retainer sleeve slides over said centering member and is glued to the centering member and the housing of the video chip. The objective housing with the optical elements is screwed on the centering member to adjust for focusing. | 09-30-2010 |
Robert Bodor, Plymouth, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20110093329 | MEDIA PREFERENCE CONSOLIDATION AND RECONCILIATION - Media preference ratings are consolidated by receiving one or more first media item ratings for a user using a first rating system, and receiving one or more second media item ratings for the user from a third party using a second rating system. The one or more second media item ratings from the second rating system are translated into media item ratings in the first rating system, and the one or more media item ratings from the third party translated in the first rating system are combined with the one or more first media item ratings to form a composite media item rating set. | 04-21-2011 |
Robert Bodor, Hoboken, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100259539 | Camera placement and virtual-scene construction for observability and activity recognition - Multiple cameras are placed at a site to optimize observability of motion paths or other tasks relating to the site, according to a quality-of-view metric. Constraints such as obstacles may be accommodated. Image sequences from multiple cameras may be combined to produce a virtual sequence taken from a desired location relative to a motion path. | 10-14-2010 |
Zoltan Bodor, Pickering CA
| Patent application number | Description | Published |
|---|---|---|
| 20100048451 | NOVEL SPILL-RESISTANT FORMULATIONS COMPRISING HYDROCOLLOIDAL POLYMERS - The invention relates to novel spill resistant formulations comprising two or more hydrocolloidal polymers and an effective amount of a pharmaceutically active agent. The formulations have a viscometric yield value of a semi-solid, and a pH and spill-resistant consistency allowing for easier preparation and use of the pharmaceutical composition. | 02-25-2010 |
| 20100222298 | SPILL RESISTANT FORMULATIONS CONTAINING CLAYS - The invention relates to novel spill resistant formulations comprising either a weak base or a weak acid as the pharmaceutical ingredient, a liquid base, a clay and a water soluble cellulose ether. The clay and cellulose ether allow for a broader pH range into which the pharmaceutically active agent may be dispersed or dissolved, and therefore allows for easier preparation and formulation of the pharmaceutical composition. | 09-02-2010 |